Sickle Cell Disease affects 100,00 Americans, and has been pretty well understood for a long time. So, why are there only two drugs available for the condition? Why are so few research dollars allocated to the problem? Well, the answers aren’t very nice.
This video was adapted from a column written by Aaron Carroll for the Upshot. Links to sources can be found there.
